Molecular Therapeutics Theme 3 Accomplishments

Theme 3: Validate clinical effectiveness of new agents and new protocols in interventional treatment trials

Scientific Accomplishments

In preclinical triple-negative breast cancer (TNBC) models, Drs. Boerner, Polin and Heilbrun, working with Dr. LoRusso, found that poly (ADP-ribose) polymerase (PARP) inhibitors such as veliparib (ABT-888) enhanced the activity of the topoisomerase 1 inhibitor irinotecan (CPT-11). Based on these results, a Phase I clinical trial was performed to examine the tolerability of combined veliparib/ironotecan in advanced solid tumor patients. Following the dose-escalation phase, an expansion cohort was opened to perform further biomarker and genomic correlative studies in two specific TNBC populations with the combined veliparib/irinotecan.

  • Lead researchers - Drs. Boerner, Polin and Heilbrun.
  • Collaborative researcher - Dr. Li

Dr. Gadgeelwas a Principal Investigators on a phase I/II study evaluating CH5424802 (alectinib), a second generation ALK (anaplastic lymphoma kinase) inhibitor in patients with ALK positive NSCLC (non-small cell lung cancer) whose disease had progressed following treatment with the first generation ALK inhibitor crizotinib. Based on the results of the phase II trial, the drug has received ‘breakthrough designation’ by the US FDA.

  • Lead researchers - Dr. Gadgeel

The Latest From Karmanos Cancer Institute

News

IN THE NEWS: McLaren Greater Lansing program helping people quit smoking for good

WILX If your new year's resolution is to quit smoking, it's not too late to get started. The Freedom From Smoking program, held at the Karmanos Ca...

Read More

IN THE NEWS: You're Not Crazy. You Just Have Cancer. The Importance of Behavioral Health Therapy During Cancer Treatment

Coping with Cancer Felicity Harper, Ph.D. , clinical psychologist and member of the Supportive Oncology Multidisciplinary Team at Karmanos, author...

Read More

Genetic counseling now offered at Karmanos’ northern Ohio cancer center

The Barbara Ann Karmanos Cancer Institute now offers genetic counseling services at the Karmanos Cancer Institute at The Toledo Clinic Cancer Cent...

Read More
News

Cancer death rate decreases by a third | WJR’s The Guy Gordon Show

Listen Now

WebMD Health Discovered – The Fight for Equity in Multiple Myeloma Care

Listen Now

ASCO Education – Impact of Implicit Racial Bias on Oncology Patient Care and Outcomes

Listen Now